Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Encysive Pharmaceuticals Inc (ENCY) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Encysive Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 887023.
Total stock buying since 2005: $37,514,247.
Total stock sales since 2005: $175,325.
Total stock option exercises since 2005: $30,000.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 15,955,234 | $37,494,793 | 0 | $0 | 0 | $0 |
| 2006 | 0 | $0 | 14,606 | $137,597 | 5,784 | $30,000 |
| 2005 | 2,000 | $19,454 | 3,372 | $37,728 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-04 | 15,955,234 | $37,494,793 | 0 | $0 | 0 | $0 |
| 2006-03 | 0 | $0 | 14,606 | $137,597 | 5,784 | $30,000 |
| 2005-10 | 2,000 | $19,454 | 0 | $0 | 0 | $0 |
| 2005-08 | 0 | $0 | 1,572 | $18,864 | 0 | $0 |
| 2005-05 | 0 | $0 | 1,800 | $18,864 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-04-14 | Pfizer Inc (10% Owner) | Buy | 1,232,412 | 2.35 | 2,896,168 |
| 2008-04-11 | Pfizer Inc (10% Owner) | Buy | 155,499 | 2.35 | 365,422 |
| 2008-04-10 | Pfizer Inc (10% Owner) | Buy | 210,794 | 2.35 | 495,365 |
| 2008-04-09 | Pfizer Inc (10% Owner) | Buy | 12,628 | 2.35 | 29,675 |
| 2008-04-08 | Pfizer Inc (10% Owner) | Buy | 29,407 | 2.35 | 69,106 |
| 2008-04-07 | Pfizer Inc (10% Owner) | Buy | 2,203,420 | 2.35 | 5,178,037 |
| 2008-04-04 | Pfizer Inc (10% Owner) | Buy | 1,728,510 | 2.35 | 4,061,997 |
| 2008-04-03 | Pfizer Inc (10% Owner) | Buy | 5,428,989 | 2.35 | 12,758,124 |
| 2008-04-02 | Pfizer Inc (10% Owner) | Buy | 6,002 | 2.35 | 14,104 |
| 2008-04-01 | Pfizer Inc (10% Owner) | Buy | 175,907 | 2.35 | 413,381 |
| 2006-03-21 | Mueller Stephen L (V.P. Finance & Administration) | Sale | 12,464 | 9.51 | 118,470 |
| 2006-03-14 | Pietruski John M (Director) | Option Ex | 2,892 | 5.19 | 15,000 |
| 2006-03-13 | Carlucci Frank C (Director) | Option Ex | 2,892 | 5.19 | 15,000 |
| 2006-03-06 | Mueller Stephen L (V.P. Finance & Administration) | Sale | 1,083 | 8.92 | 9,660 |
| 2006-03-01 | Mueller Stephen L (V.P. Finance & Administration) | Sale | 1,059 | 8.94 | 9,467 |
| 2005-10-11 | Given Bruce D (CEO) | Buy | 2,000 | 9.73 | 19,454 |
| 2005-08-10 | Dixon Richard A F (CSO) | Sale | 1,572 | 12.00 | 18,864 |
| 2005-05-26 | Maetzold Derek J (Sales) | Sale | 1,800 | 10.48 | 18,864 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENCY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Encysive Pharmaceuticals Inc (symbol ENCY, CIK number 887023) see the Securities and Exchange Commission (SEC) website.